AMN Healthcare Services (NYSE:AMN) Delivers Strong Q2 CY2026 Numbers, Stock Jumps 11.5%
AMN Healthcare Services (NYSE:AMN) reported Q2 CY2026 revenue of $673.2 million, up 2.3% year on year, beating Wall Street expectations. Next-quarter revenue guidance was $647.5 million at the midpoint, about 4.7% above consensus. Non-GAAP EPS was $0.77, above estimates, and the stock rose 11.5% to $34.29. Analysts expect full-year EPS to fall to $0.88.
How this was made

The 30-second read
Why it matters
The article frames the quarter as a beat on revenue and adjusted EPS plus better-than-expected next-quarter revenue guidance, while also highlighting weak longer-term growth trends and a large expected EPS decline over the next 12 months.
Market read
AMN’s earnings and guidance drove an 11.5% stock jump, but the forward EPS outlook described in the article introduces a fundamental overhang.
What to watch
Traveler count is down YoY while revenue grew, suggesting pricing rather than volume; traders should scrutinize whether guidance durability depends on temporary staffing rates.
Background
AMN Healthcare Services provides healthcare workforce solutions and reports traveler-on-assignment metrics alongside financial results.
Ticker impact
AMN reported Q2 CY2026 revenue of $673.2M (+2.3% YoY) and adjusted EPS of $0.77, beating consensus, and guided next-quarter revenue above expectations.
Bullish bias for the next few sessions, with elevated volatility as traders reconcile beat-and-guide versus expected 12-month EPS contraction.
The article cites a same-day stock jump of 11.5% plus beat on EPS and revenue, but also states sell-side expects full-year EPS to fall 74.7% from $3.48 to $0.88, which can cap follow-through.
Market effects
Healthcare staffing demand and pricing dynamics may look steadier if AMN’s traveler trends and margin expansion persist.
No specific regional impact described beyond US healthcare staffing operations.
Limited global spillover; story is company-specific within US staffing.
Counterpoint
The beat may be partly price-driven and margin may not sustain, especially with the article’s expectation of a steep full-year EPS drop.
Key entities
- public_companyAMN Healthcare Services
NYSE-listed healthcare staffing firm reporting Q2 CY2026 results and next-quarter revenue guidance.

